Literature DB >> 3158390

Cardiomegaly and haemodynamics in rats with a transplantable growth hormone-secreting tumour.

D G Penney, J C Dunbar, M S Baylerian.   

Abstract

To investigate cardiovascular changes in experimental acromegaly, a growth hormone-secreting tumour (MtT-W-15) was implanted in adult female rats. Somatic and tumour growth occurred steadily during the 8 week study period, as did an increase in serum growth hormone titre. Weight of left ventricle and right ventricle increased directly with tumour growth, both on an absolute basis and when compared with normal rats of equal body weight. Atrial weight also increased substantially. Haematocrit declined sharply at first, and more slowly later with increasing tumour weight. Haemodynamic measurements were made on these animals at two stages of tumour growth using an anaesthetised open-chest preparation. Cardiac index (per g body wt), stroke index, stroke work, left ventricle +dP/dtmax, and dF/dtmax of aortic flow were greatly elevated in rats with the largest tumours (longer duration), and to a lesser extent in those with smaller tumours (shorter duration). Systemic peripheral resistance and heart rate were depressed. Ventricular weight increased non-linearly with increases in cardiac index. Cardiac output, stroke volume, stroke work and dF/dtmax normalised per g left ventricle weight were also elevated. Splenomegaly accompanied tumour growth; however, splenectomy of tumour-bearing animals failed to prevent development of anaemia and cardiomegaly. While a direct effect of elevated growth hormone provides the best explanation for development of cardiomegaly in this model, volume work overloading due to anaemia and water retention may be a contributory cause.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158390     DOI: 10.1093/cvr/19.5.270

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  8 in total

Review 1.  Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects.

Authors:  Lindsey J Anderson; Jamie M Tamayose; Jose M Garcia
Journal:  Mol Cell Endocrinol       Date:  2017-06-09       Impact factor: 4.102

2.  Increase in T-type calcium current in atrial myocytes from adult rats with growth hormone-secreting tumors.

Authors:  X P Xu; P M Best
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

3.  Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle.

Authors:  J Timsit; B Riou; J Bertherat; C Wisnewsky; N S Kato; A S Weisberg; J Lubetzki; Y Lecarpentier; S Winegrad; J J Mercadier
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

Review 4.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

5.  The GH/IGF-1 Axis and Heart Failure.

Authors:  Graziella Castellano; Flora Affuso; Pasquale Di Conza; Serafino Fazio
Journal:  Curr Cardiol Rev       Date:  2009-08

6.  Effects of growth hormone in rats with postinfarction left ventricular dysfunction.

Authors:  R Yang; S Bunting; N Gillett; R G Clark; H Jin
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727

7.  Effect of fermented oyster extract on growth promotion in Sprague-Dawley rats.

Authors:  Hyesook Lee; Hyun Hwang-Bo; Seon Yeong Ji; Min Yeong Kim; So Young Kim; Minji Woo; Young-Sam Keum; Jeong Sook Noh; Joung-Hyun Park; Bae-Jin Lee; Gi-Young Kim; Eui Kyun Park; Young-Chae Chang; You-Jin Jeon; Yung Hyun Choi
Journal:  Integr Med Res       Date:  2020-04-07

Review 8.  GH and the cardiovascular system: an update on a topic at heart.

Authors:  Jörgen Isgaard; Michele Arcopinto; Kristjan Karason; Antonio Cittadini
Journal:  Endocrine       Date:  2014-06-28       Impact factor: 3.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.